glutathione and triple negative breast cancer Frontiers Glutathione depletion and dihydroorotate dehydrogenase
Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect Heterogeneity and transcriptional drivers of triple negative breast cancer: Cell Reports Oncology Letters Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy: Cell Metabolism Glutathione peroxidase 4 (GPX4) and obesity interact to impact tumor progression and treatment response in triple negative breast cancer Cancer & Metabolism Springer Nature Link A review of biological targets and therapeutic approaches in the management of triple negative breast cancer ScienceDirect
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 20 - Sep 25





